EVIDENCE BASE
Peer-reviewed references behind the molecules in our catalog. Selection favors in-vitro and preclinical investigation; receptor-agonist binding studies; and dose-response in animal models. Sponsored content is never accepted on this page.
Multiple authors, peer-reviewed review · New England Journal of Medicine · 2024
Phase 3 efficacy and dose-response results for the amylin + incretin co-administration reference compounds. Cited as the reference for ongoing amylin-receptor research and for combined-receptor pharmacology in cell-based assays.
Multiple authors, peer-reviewed review · New England Journal of Medicine · 2024
Phase 3 efficacy and dose-response results for the amylin + incretin co-administration reference compounds. Cited as the reference for ongoing amylin-receptor research and for combined-receptor pharmacology in cell-based assays.
Multiple authors, peer-reviewed review · New England Journal of Medicine · 2024
Phase 3 efficacy and dose-response results for the amylin + incretin co-administration reference compounds. Cited as the reference for ongoing amylin-receptor research and for combined-receptor pharmacology in cell-based assays.
Multiple authors, peer-reviewed review · New England Journal of Medicine · 2024
Phase 3 efficacy and dose-response results for the amylin + incretin co-administration reference compounds. Cited as the reference for ongoing amylin-receptor research and for combined-receptor pharmacology in cell-based assays.
Multiple authors, peer-reviewed review · New England Journal of Medicine · 2024
Phase 3 efficacy and dose-response results for the amylin + incretin co-administration reference compounds. Cited as the reference for ongoing amylin-receptor research and for combined-receptor pharmacology in cell-based assays.
A note on selection
We prioritize in-vitro receptor binding studies, ex-vivo tissue assays, dose-response work in rodent and primate models, and analytical-method papers (HPLC, mass-spec, endotoxin). Studies in human subjects are listed for context only and are not endorsed as evidence of human applicability of any catalog product.